Marshall Wace’s Lifestance Health LFST Stock Holding History

Marshall Wace’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Sell	237,927 -100,831	-30%	-$702K	﹤0.01%	1934
2025 Q4	$2.38M	Sell	338,758 -1,049,866	-76%	-$6.34M	﹤0.01%	1496
2025 Q3	$7.64M	Buy	+1,388,624	New	+$6.8M	0.01%	1023
2025 Q2	–	Sell	-887,192	Closed	-$5.91M	–	2955
2025 Q1	$5.91M	Buy	887,192 +531,268	+149%	+$4.04M	0.01%	985
2024 Q4	$2.62M	Buy	+355,924	New	+$2.55M	﹤0.01%	1332
2024 Q2	–	Sell	-122,243	Closed	-$754K	–	2761
2024 Q1	$754K	Buy	+122,243	New	+$823K	﹤0.01%	1768
2023 Q4	–	Sell	-73,766	Closed	-$507K	–	2422
2023 Q3	$507K	Buy	+73,766	New	+$598K	﹤0.01%	1722
2023 Q2	–	Sell	-295,108	Closed	-$2.19M	–	2734
2023 Q1	$2.19M	Buy	+295,108	New	+$1.64M	﹤0.01%	1409
2022 Q4	–	Sell	-17,231	Closed	-$114K	–	3191
2022 Q3	$114K	Buy	+17,231	New	+$120K	﹤0.01%	3174

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SPIG

Silversmith Partners I GP Boston, Massachusetts $39.2M AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Marshall Wace's LFST Position: Q1 2026 in Review

Marshall Wace reduced its Lifestance Health (LFST) stake by 30% in Q1 2026, selling an estimated $702K and leaving 237,927 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Marshall Wace first reported a position in LFST in Q3 2022 and has held it in 9 quarters since. The position peaked at $7.64M in Q3 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

Marshall Wace held 237,927 shares of Lifestance Health worth $1.52M as of Q1 2026.
Marshall Wace sold 100,831 Lifestance Health shares in Q1 2026, an estimated $702K.
Lifestance Health made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1934 holding.
Marshall Wace first reported a position in Lifestance Health in Q3 2022 and has held it in 9 quarters since.
Marshall Wace's Lifestance Health position peaked at $7.64M in Q3 2025.
228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.